中药加化疗治疗晚期非小细胞肺癌疗效分析

为探讨中药及化疗在晚期非小细胞肺癌治疗中的价值和规律。对５８例晚非小细胞肺癌患者给予中药加化疗治疗，并与２８例单纯化职及２４例单纯中药治疗进行比较。３组近期客观疗效相近，有效率（ＣＲ＋ＰＲ）分别为２２．９％、１３．６％及１３．６（Ｐ〉０．０５）。中位生存期以中西组最长，为１０．２个月，中药组次之，为８．０个月，化疗组最短，仅５．３个月，远期和存率中西组与中药组相近（Ｐ〉０．０５），均显著高于化疗组

Therapeutic Effect of Chinese Medicinal Herbs Combined with Chemotherapy on Advanced Non -Small Cell Lung Cancer

To observe the effect of Chinese medicinal herbs (CMH) and chemotherapy on non small cell imp cancer. Methods: Comparing the therapeutic effects of three treatment regimens on 58 advanced non-small cell imp cancer (NSCLC) patients who were treated with CMH plus chemotherapy (CT), 28 cases treated with CT only, and 24 cases treated with CMH alone. Results: Effective rates (partial remission complete remission) were 22. 9% in CMH CT group, 13.6% both in CT and in CMH group. There were no significant differences between these three groups according to the short-term results (P >0. 05). Mean survival time (month) for CMH CT, CT and CMH grouPS were 10.2, 5.3 and 8.0 respectively. The survival rate (Kaplan Meter method) of both CMH CT and CMH group were significantly higher than that of CT group(p <0.01, P <0.05) but no significant difference between CMH and CMH CT group (P>0.05). Conclusion: Chinese medicinal herbs were helpful to improve median survival time and survival rate of patients with advanced NSCLC.